Here are relevant reports on : clinical-mass-spectrometry-market
-
Inorganic Mass Spectrometry Market by Product (Inductively Coupled Plasma-Mass Spectrometry, Isotope Ratio Mass Spectrometry) & Application (Nuclear Science, Metrology, and Industrial Chemistry) - Analysis & Global Forecast to 2020
Inorganic Mass spectrometry is an analytical technique used for multi elemental determination of elements at the trace and ultratrace level in high-purity materials. The mass spectrometry market is segmented on the basis of product and application. The mass spectrometry market, by product, is segmented into isotope ratio mass spectrometry (IRMS), multi-collector mass spectrometry (MC/IRMS), inductively coupled plasma mass spectrometry (ICP/MS), and high resolution trace mass spectrometry (HR Trace/MS)
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Proteomics Market by Instrumentation [Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray], Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery) - Forecast to 2030
The Asia Pacific Proteomics Market, valued at USD 7.82 billion in 2024, stood at USD 8.57 billion in 2025 and is projected to advance at a resilient CAGR of 14.1% from 2025 to 2030, culminating in a forecasted valuation of USD 16.61 billion by the end of the period. Proteomics focuses on measuring dynamic protein expression, modifications, and interactions at scale, enabling deeper insights into disease biology and treatment response for oncology, neurology, and other complex indications.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Protein Characterization Market / Protein Identification Market by Instruments (Chromatography, Electrophoresis, Mass Spectrometry), Consumables & Services, Application (Clinical Diagnosis, Drug Discovery), End User (Pharma, Biotech, CROs) & Region - Global Forecast to 2026
The global protein characterization market growth is primed to transition from $12.6 billion in 2021 to $23.9 billion by 2026, showcasing a strong CAGR of 13.7%. Growth in the protein identification market can mainly be attributed to factors such as rising acceptance of personalized medicine, technological advancement and increased drug discovery & development activities.
- Published: September 2021
- Price: $ 4950
- TOC Available:
-
Europe Proteomics Market by Instrumentation [Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray], Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery) - Forecast to 2030
The Europe Proteomics market, valued at USD9.80 billion in 2024, stood at USD10.55 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of USD18.77 billion by the end of the period.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
North America Proteomics Market by Instrumentation (Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray), Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery)- Forecast to 2030
The North America Proteomics market, valued at USD13.06 billion in 2024, stood at USD14.11 billion in 2025 and is projected to advance at a resilient CAGR of 12.7% from 2025 to 2030, culminating in a forecasted valuation of USD25.62 billion by the end of the period. The growing use of proteomics in precision oncology, cardiology, and other complex diseases, together with strong momentum in clinical trials, is driving demand for high-throughput, reliable platforms in hospitals and research centers.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Clinical Mass Spectrometry Market by Component (Detector, Mass Analyzer, Ion Source, Vacuum System), Technique (LC-MS, GC-MS, Standalone MS), Application (TDM, Newborn Screening, Hormonal Testing), Installed Base & Replacement Rate - Global Forecast to 2031
The global Clinical Mass Spectrometry market, valued at US$1.75 billion in 2024, stood at US$1.92 billion in 2025 and is projected to advance at a resilient CAGR of 9.5% from 2025 to 2031, culminating in a forecasted valuation of US$3.31 billion by the end of the period. Demand is underpinned by the shift from immunoassay-based methods to LC-MS platforms for therapeutic drug monitoring, endocrine testing, vitamin analysis, and newborn screening, where higher specificity and the ability to run multiplex panels on a single platform improve result reliability and workflow efficiency.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Endocrine Testing Market by Type (Thyroid, Insulin, HCG, Prolactin, Progesterone, LH, FSH), Technology (Immunoassay, Tandem Mass Spectroscopy, Clinical Chemistry), End User (Hospitals, Clinical Laboratories) - Global Forecast to 2027
The global Endocrine Testing Market is expected to reach USD xx billion by 2027 from USD xx billion in 2022, at a CAGR of xx%. The growth in this market is driven by the increasing prevalence of the endocrine disorders such as thyroid imbalance, diabetes, Polycystic Ovary Syndrome, etc. Also, the increasing government funding and rising awareness for the endocrine hormone tests for the diagnosis and management of the endocrine disorder have also fueled the growth of the market.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Glycomics Market / Glycobiology Market by Product (Enzymes (Glycosidases, Transferases), Instruments (Mass Spectrometry, Chromatography, Arrays), Kits, Carbohydrates, Reagents), Application (Drug Discovery, Diagnostics), End User - Global Forecast to 2027
The global glycomics market in terms of revenue was estimated to be worth $1.8 Billion in 2022 and is poised to reach $3.7 billion by 2027, growing at a CAGR of 15.5% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Q-TOF Mass Spectrometry Market by Application (Biotech Applications, Pharmaceutical Applications, Food & Beverage Testing, Environmental Testing, Petrochemical Applications), and Region (North America, Europe, APAC, and Row) & Geography
The global Q-TOF mass spectrometry market is expected to grow at a CAGR of 7.7%. The growth of this market is majorly driven by the technological advancements pertaining to Q-TOF mass spectrometry technology, government initiatives for pollution control and environmental testing, high expenditure on R&D activities of mass spectrometry supplements in pharmaceutical and biotechnological applications, stringent government regulations regarding drug safety, and increased focus on producing high-quality food. However, the high costs of Q-TOF instruments is restraining the growth of the Q-TOF mass spectrometry market. Waters Corporation (US), Agilent Technologies (US), and SCIEX (Subsidiary of Danaher) (US) are the key players in the Q-TOF mass spectrometry market. Other players involved in this market are Bruker (US) and Shimadzu Corporation (Japan).
- Published: July 2018
- Price: $ 4950
- TOC Available:
-
Biotechnology Instruments Market by Product (LC, NGS, Mass Spectrometry, Electrophoresis, Bioreactors, Incubators, Centrifuges, Spectrophotometers), Application (Biotech Manufacturing, Spatial Cell Analysis, Genomics, Proteomics), End User (Biopharma Cos, CROs, Academia) - Global Forecasts to 2027
The global biotechnology instruments market is projected to reach USD 35.9 billion by 2027 from USD 21.4 billion in 2022, at a CAGR of 9% during the forecast period
- Published: April 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
